Table 2.

TERT analysis on FFPE samples from a Western Australian aGCT cohort

Patient #AgeTissue stage/statusTERT Status -124Follow-up/Interval (yr. month)Follow-up tissue stage/statusTERT Status -124
1551WT8.05Disease free
2431HET17.06Disease free
3711WT11.03Disease free
4761HET19.06Disease free
5371HET16.03Disease free
6631HET18.11Disease free
7501WT14.04Disease free
8511HET16.11Disease free
9641WT5.05Disease free
10351WT6.02Disease free
11541HET12.10Disease free
12431WT10.07Disease free
13441HET10.10Disease free
14841Homozygous5.01Disease free
15521HET9.05Disease free
1676PrimaryHET12RecurrentHomozygous
1765PrimaryWT10.06RecurrentWT
1878PrimaryWT6.03RecurrentHET
1967PrimaryWT9.09RecurrentHET
2062PrimaryWT5.03RecurrentHET
2155PrimaryHET2.10RecurrentHET
2249PrimaryHET2.01RecurrentHET
2342PrimaryWT7.04RecurrentWT
2447PrimaryWT12.02RecurrentWT
2555PrimaryWT4.07RecurrentHET
2640PrimaryWT11.04RecurrentHET
2754PrimaryHET13.08RecurrentHET
2845PrimaryWT5RecurrentWT
2950PrimaryHET18.07RecurrentHET
3046PrimaryWT6.10RecurrentWT
3168PrimaryWT4.02
3258PrimaryHET9.10